Abstract：This article reports a case of limb-girdle muscular dystrophy type 1B (LGMD1B) caused by a novel splicing heterozygous mutation in the LMNA gene. The proband presented with progressive aggravation of weakness in walking. There was no atrophy of the scapular muscles and the lower-extremity proximal muscles, with normal muscle tension of the extremities, grade 4 muscle strength in the upper and lower extremities, and positive Gower sign. The level of creatine kinase was 779 U/L. Muscle hematoxylin-eosin staining showed muscular dystrophy, and there was no significant reduction in the expression of Lamin A protein. Second-generation sequencing revealed a novel splicing heterozygous mutation, c.810+2T > C, in the LMNA gene, while this locus was normal in his parents. GERP++RS software predicted that the mutation site was highly conservative. Human Splice Finder and Spliceman software predicted that the mutation might be a pathogenic mutation. ExPASy software predicted that the new amino acid sequence became shorter. There were two sequences of mRNA in the patient's muscle:one was the normal sequence, which accounted for 92.2%; the other was partial intron 4 retention, which was the abnormal splice variant accounting for 7.8%. LGMD1B is a type of autosomal dominant inherited myopathy caused by a mutation in the LMNA gene located on the autosomal 1q22. This study extends the mutation spectrum of the LMNA gene and provides help to the diagnosis of LGMD1B.
YU Xin-Xiu,ZHONG Jing-Zi,GUAN Hong-Lin et al. Clinical and genetic features of limb-girdle muscular dystrophy type 1B: a case report[J]. CJCP, 2018, 20(12): 1015-1019.
Thompson R, Straub V. Limb-girdle muscular dystrophies-international collaborations for translational research[J]. Nat Rev Neurol, 2016, 12(5):294-309.
[4]
Muchir A, Bonne G, van der Kooi AJ, et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)[J]. Hum Mol Genet, 2000, 9(9):1453-1459.
[5]
Janin A, Bauer D, Ratti F, et al. SMAD6 overexpression leads to accelerated myogenic differentiation of LMNA mutated cells[J]. Sci Rep, 2018, 8(1):5618.
[6]
Lim KH, Fairbrother WG. Spliceman--a computational web server that predicts sequence variations in pre-mRNA splicing[J]. Bioinformatics, 2012, 28(7):1031-1032.
[7]
Davydov EV, Goode DL, Sirota M, et al. Identifying a high fraction of the human genome to be under selective constraint using GERP++[J]. PLoS Comput Biol, 2010, 6(12):1-13.
[8]
Worman HJ. Nuclear lamins and laminopathies[J]. J Pathol, 2011, 226(2):316-325.
[9]
Mercuri E, Brown SC, Nihoyannopoulos P, et al. Extreme variability of skeletal and cardiac muscle involvement in patients with mutations in exon 11 of the lamin A/C gene[J]. Muscle Nerve, 2005, 31(5):602-609.
[10]
Seong MW, Cho A, Park HW, et al. Clinical applications of next-generation sequencing-based gene panel in patients with muscular dystrophy:Korean experience[J]. Clin Genet, 2016, 89(4):484-488.
Maraldi NM, Capanni C, Cenni V, et al. Laminopathies and lamin-associated signaling pathways[J]. J Cell Biochem, 2011, 112(4):979-992.
[13]
van Engelen BG, Muchir A, Hutchison CJ, et al. The lethal phenotype of a homozygous nonsense mutation in the lamin A/C gene[J]. Neurology, 2005, 64(2):374-376.
[14]
Geiger SK, Bar H, Ehlermann P, et al. Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia[J]. J Mol Med (Berl), 2008, 86(3):281-289.
[15]
Rankin J, Ellard S. The laminopathies:a clinical review[J]. Clin Genet, 2006, 70(4):261-274.
[16]
Rogozhina Y, Mironovich S, Shestak A, et al. New intronic splicing mutation in the LMNA gene causing progressive cardiac conduction defects and variable myopathy[J]. Gene, 2016, 595(2):202-206.
[17]
Todorova A, Halliger-Keller B, Walter MC, et al. A synonymous codon change in the LMNA gene alters mRNA splicing and causes limb girdle muscular dystrophy type 1B[J]. J Med Genet, 2003, 40(10):e115.
